236 related articles for article (PubMed ID: 25501959)
21. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
Bitoun M; Bevilacqua JA; Prudhon B; Maugenre S; Taratuto AL; Monges S; Lubieniecki F; Cances C; Uro-Coste E; Mayer M; Fardeau M; Romero NB; Guicheney P
Ann Neurol; 2007 Dec; 62(6):666-70. PubMed ID: 17932957
[TBL] [Abstract][Full Text] [Related]
22. Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation.
Hanna N; Bouhenni R; Gupta B; Abu-Amero KK; Wollmann R; Edward DP
Ophthalmic Genet; 2013; 34(1-2):83-6. PubMed ID: 22924779
[TBL] [Abstract][Full Text] [Related]
23. Clinical, Electrophysiology, and Pathology Features of Dynamin Centronuclear Myopathy: A Case Report and Review of Literature.
Verma S; Balasubramanian SB
J Clin Neuromuscul Dis; 2016 Dec; 18(2):84-88. PubMed ID: 27861221
[TBL] [Abstract][Full Text] [Related]
24. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
[TBL] [Abstract][Full Text] [Related]
25. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
[TBL] [Abstract][Full Text] [Related]
26. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
[TBL] [Abstract][Full Text] [Related]
27. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
[TBL] [Abstract][Full Text] [Related]
29. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
[TBL] [Abstract][Full Text] [Related]
30. Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy.
Fujise K; Okubo M; Abe T; Yamada H; Takei K; Nishino I; Takeda T; Noguchi S
Hum Mutat; 2022 Feb; 43(2):169-179. PubMed ID: 34837441
[TBL] [Abstract][Full Text] [Related]
31. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
[TBL] [Abstract][Full Text] [Related]
32. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation.
Romero NB; Bevilacqua JA; Oldfors A; Fardeau M
Neuromuscul Disord; 2011 Feb; 21(2):148; author reply 148-9. PubMed ID: 21247764
[No Abstract] [Full Text] [Related]
33. Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort.
Catteruccia M; Fattori F; Codemo V; Ruggiero L; Maggi L; Tasca G; Fiorillo C; Pane M; Berardinelli A; Verardo M; Bragato C; Mora M; Morandi L; Bruno C; Santoro L; Pegoraro E; Mercuri E; Bertini E; D'Amico A
Neuromuscul Disord; 2013 Mar; 23(3):229-38. PubMed ID: 23394783
[TBL] [Abstract][Full Text] [Related]
34. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
Gibbs EM; Clarke NF; Rose K; Oates EC; Webster R; Feldman EL; Dowling JJ
J Mol Med (Berl); 2013 Jun; 91(6):727-37. PubMed ID: 23338057
[TBL] [Abstract][Full Text] [Related]
35. Centronuclear myopathies: a widening concept.
Romero NB
Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
[TBL] [Abstract][Full Text] [Related]
36. A rare case of centronuclear myopathy with
Aghbolaghi AG; Lechpammer M
Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838
[TBL] [Abstract][Full Text] [Related]
37. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
Tinelli E; Pereira JA; Suter U
Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
[TBL] [Abstract][Full Text] [Related]
38. A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres.
Casar-Borota O; Jacobsson J; Libelius R; Oldfors CH; Malfatti E; Romero NB; Oldfors A
Neuromuscul Disord; 2015 Apr; 25(4):345-8. PubMed ID: 25633151
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and biopsy-based myopathological features of 5 cases with centronuclear myopathy].
Li HH; Liu SP; Li W; Zhao YY; Wu JL; Li DN; Yan CZ
Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):856-9. PubMed ID: 19099905
[TBL] [Abstract][Full Text] [Related]
40. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
